Free Trial

Beauty Health (SKIN) Competitors

Beauty Health logo
$1.98 +0.39 (+24.21%)
As of 03:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SKIN vs. SIBN, BBNX, EMBC, AXGN, ZIMV, BVS, CBLL, AVNS, KIDS, and SMLR

Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include SiBone (SIBN), Beta Bionics (BBNX), Embecta (EMBC), AxoGen (AXGN), ZimVie (ZIMV), Bioventus (BVS), CeriBell (CBLL), AVANOS MEDICAL (AVNS), OrthoPediatrics (KIDS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

Beauty Health vs. Its Competitors

SiBone (NASDAQ:SIBN) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

Beauty Health has higher revenue and earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SiBone$167.18M4.02-$30.91M-$0.56-28.16
Beauty Health$322.47M0.77-$29.10M-$0.41-4.82

Beauty Health has a net margin of -11.94% compared to SiBone's net margin of -12.83%. SiBone's return on equity of -14.20% beat Beauty Health's return on equity.

Company Net Margins Return on Equity Return on Assets
SiBone-12.83% -14.20% -10.38%
Beauty Health -11.94%-67.91%-5.56%

SiBone presently has a consensus target price of $23.67, suggesting a potential upside of 50.07%. Beauty Health has a consensus target price of $2.08, suggesting a potential upside of 5.49%. Given SiBone's stronger consensus rating and higher possible upside, research analysts plainly believe SiBone is more favorable than Beauty Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SiBone
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Beauty Health
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

98.1% of SiBone shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 4.0% of SiBone shares are owned by insiders. Comparatively, 41.0% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SiBone has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

In the previous week, Beauty Health had 3 more articles in the media than SiBone. MarketBeat recorded 17 mentions for Beauty Health and 14 mentions for SiBone. Beauty Health's average media sentiment score of 0.73 beat SiBone's score of 0.56 indicating that Beauty Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SiBone
3 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Beauty Health
7 Very Positive mention(s)
5 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Beauty Health beats SiBone on 10 of the 16 factors compared between the two stocks.

Get Beauty Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SKIN vs. The Competition

MetricBeauty HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$248.84M$7.33B$5.45B$9.68B
Dividend YieldN/A2.83%3.99%4.14%
P/E Ratio-4.8264.0330.0324.95
Price / Sales0.7725.37376.7977.81
Price / Cash25.1526.5935.9458.58
Price / Book4.8218.008.165.68
Net Income-$29.10M$239.96M$3.25B$265.58M
7 Day Performance29.08%2.37%1.08%2.52%
1 Month Performance-5.95%-2.98%2.75%1.86%
1 Year Performance53.10%21.97%28.51%24.27%

Beauty Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SKIN
Beauty Health
0.4929 of 5 stars
$1.98
+24.2%
$2.08
+5.5%
+27.2%$248.84M$322.47M-4.821,030Earnings Report
Gap Up
High Trading Volume
SIBN
SiBone
4.1466 of 5 stars
$17.90
+2.9%
$22.50
+25.7%
+15.6%$741.07M$167.18M-27.97350Earnings Report
Analyst Forecast
Analyst Revision
High Trading Volume
BBNX
Beta Bionics
2.5011 of 5 stars
$16.42
+0.1%
$22.56
+37.4%
N/A$712.91M$65.12M0.00294
EMBC
Embecta
4.7615 of 5 stars
$9.79
-1.7%
$19.00
+94.1%
-25.2%$582.09M$1.08B10.882,100News Coverage
Earnings Report
Dividend Announcement
Gap Up
AXGN
AxoGen
2.3208 of 5 stars
$12.55
-0.9%
$24.50
+95.2%
+77.7%$577.04M$187.34M-83.66450Analyst Revision
ZIMV
ZimVie
0.894 of 5 stars
$18.77
+0.1%
$17.75
-5.4%
+10.6%$529.05M$449.75M-26.811,770
BVS
Bioventus
2.9053 of 5 stars
$6.32
+2.3%
$13.75
+117.6%
-7.1%$519.15M$567.70M-10.361,200News Coverage
CBLL
CeriBell
2.8905 of 5 stars
$15.23
+7.7%
$32.14
+111.0%
N/A$511.06M$65.44M0.00N/ANews Coverage
Earnings Report
Analyst Revision
AVNS
AVANOS MEDICAL
1.6337 of 5 stars
$11.28
+2.7%
N/A-52.4%$507.76M$687.80M-1.352,227Earnings Report
KIDS
OrthoPediatrics
3.8987 of 5 stars
$20.53
+0.7%
$35.83
+74.5%
-29.2%$495.20M$204.73M-11.73200Earnings Report
Analyst Forecast
SMLR
Semler Scientific
3.2885 of 5 stars
$35.37
+2.6%
$82.00
+131.8%
+43.1%$475.15M$56.29M-13.55120Earnings Report
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:SKIN) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners